会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • SILENCING DEVICE AND METHOD FOR NEEDLELESS SYRINGE
    • 用于无瞄准器的静音装置和方法
    • WO03011380A2
    • 2003-02-13
    • PCT/GB0203412
    • 2002-07-25
    • POWDERJECT RES LTDKENDALL MARK ANTHONY FERNANCE
    • KENDALL MARK ANTHONY FERNANCE
    • A61M5/24A61M5/30
    • A61M5/3015A61M5/24
    • The invention provides a silencer and silencing method which ensures adequate silencing with no deleterious increase in back pressure (which creates a lift-off force) or decrease in device performance. Pressurised gas is supplied to a driver chamber by a bleed-hole having an effective bleed-hole area and, during use of the device for particle delivery, gas is vented to the atmosphere via a silencer having an effective venting area. The bleed-hole area and venting area are chosen to ensure that the mass flow rate of gas through the effective venting are is substantially equal to or greater than the mass flow rate of gas through the effective bleed-hole area. This ensures that there is no build up of gas in the silencer device which tends to increase back pressure and hence lift-off force. Preferred embodiments of the device comprise a silencer having a large volume and a small particle exit opening. Further, there is disclosed an embodiment using one or more transfer ducts to assist particle mixing.
    • 本发明提供了一种消音器和消音方法,其确保足够的消音而没有有害的背压增加(产生剥离力)或降低了装置性能。 通过具有有效排气孔区域的排放孔将加压气体供应到驱动器腔室,并且在使用用于颗粒输送的装置期间,通过具有有效排气区域的消音器将气体排放到大气中。 选择排气孔面积和排气面积以确保通过有效排气的气体的质量流率基本上等于或大于通过有效排气孔面积的气体的质量流率。 这确保了在消音器装置中没有积聚气体,其倾向于增加背压和因此提升力。 该装置的优选实施例包括具有大体积和小颗粒出口的消音器。 此外,公开了使用一个或多个传输管道来辅助颗粒混合的实施例。
    • 9. 发明申请
    • IMPROVED VACCINE
    • 改进的疫苗
    • WO2009074861A3
    • 2009-12-17
    • PCT/IB2008003451
    • 2008-12-09
    • POWDERJECT RES LTDLYNCH DEBORAH TAYLOR
    • LYNCH DEBORAH TAYLOR
    • A61K39/145C07K14/11
    • A61K39/145A61K39/12A61K2039/53A61K2039/545A61K2039/6075A61K2039/70C12N2760/16134C12N2760/16234
    • The present invention relates to the fields of molecular biology and immunology and generally to reagents useful in nucleic acid immunisation techniques and vaccination. The present invention further relates to novel vaccine compositions capable of eliciting an enhanced immune response against influenza virus. More specifically, the present invention relates to a vaccine comprising a nucleic acid sequence encoding at least one influenza virus antigen and a protein comprising the at least one antigen for separate, sequential or concomitant administration. The present invention further provides a process for preparing the vaccine and a method of eliciting an immune response against influenza virus infection. The present invention is also directed to a use of a vaccine for profilatic or therapeutic immunization against infections caused by influenza virus.
    • 本发明涉及分子生物学和免疫学领域,通常涉及可用于核酸免疫技术和疫苗接种的试剂。 本发明还涉及能够引发针对流感病毒的增强的免疫应答的新型疫苗组合物。 更具体地,本发明涉及包含编码至少一种流感病毒抗原的核酸序列和包含至少一种抗原的蛋白质的疫苗,用于单独,顺序或伴随施用。 本发明还提供了制备疫苗的方法和引发针对流感病毒感染的免疫应答的方法。 本发明还涉及疫苗用于针对由流感病毒引起的感染进行痤疮或治疗性免疫的用途。